Disclosures of Conflict of Interest
It is the policy of AcademicCME that all faculty, instructors, and planners disclose real or apparent conflicts of interest relating to the topics of this educational activity.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CE activity:
| Faculty | Relationship Identified With: |
| Steven Chen | Consultant for digital Media: Pfizer, Novartis |
| Juan Carlos Ivancevich, M | Consultant: Laboratorios Casasco Argentina, Faes Farma, Spain, Sanofi; Speaker: Laboratorios Casasco Argentina, Laboratorios Bago, Bolivia, Abbott, Ecuador |
| Brian S. Kim, MD, MTR, FAAD | Consultant: Abbvie, Allmirall, Amagma, AstraZeneca, Cara Therapeutics, Galerma, LEO Pharma, Pfizer,Regeneron, Sanofi, Recens Medical, Trevi Therapeutics, Abrax Japan, Granular Therapeutics, Bellus Health, Bristol-Myers Squibb, Daewoong, Eli Lilly, Incyte, OM Pharma, Shaperon, Jannsen, Novartis; Research Grant: Cara Therapeutics and LEO Pharma |
| Jonathan I Silverberg, MD, PhD, MPH | Consultant: Abbvie, Afyx, Aobiome, Arena, Asana, Aslan, BioMX, Biosion, Bluefin, Bodewell, Boehringer- Ingelheim, Cara, Castle Biosciences, Celgene, Connect Biopharma, Dermavant, Dermira, Dermtech, Eli Lilly, Galderma, GlaxoSmithKline, Incyte, Kiniksa, Leo Pharma, Luna, Menlo, Novartis, Optum, Pfizer, RAPT, Regeneron, Sanofi-Genzyme, Shaperon, Sidekick Health, Union Speaker: Abbvie, Eli Lilly, Leo Pharma, Pfizer, Regeneron, Sanofi-Genzyme Institution received grants: Galderma, Pfizer |
All relevant financial relationships with ineligible companies for this educational content have been mitigated.
